Featured Post

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...

Tuesday, April 25, 2017

Zydus Cadila gets USFDA nod for anti-hypertensive tablets

http://ift.tt/2oMaKGK
Zydus Cadila gets USFDA nod for anti-hypertensive tablets The company has received “final approval from the United States Food and Drug Administration (USFDA) to market olmesartan medoxomil tablets in the strengths of 5 mg, 20 mg and 40 mg”, Cadila Healthcare said in a filing to BSE. The drug is an anti-hypertensive and will be produced at the group#39;s formulations manufacturing facility in Ahmedabad, it added.

April 25, 2017 at 02:32PM

http://ift.tt/2q1rIRS

from

http://ift.tt/2q1rIRS


No comments:

Post a Comment